138 related articles for article (PubMed ID: 31354491)
1. Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models.
Clemente N; Argenziano M; Gigliotti CL; Ferrara B; Boggio E; Chiocchetti A; Caldera F; Trotta F; Benetti E; Annaratone L; Ribero S; Pizzimenti S; Barrera G; Dianzani U; Cavalli R; Dianzani C
Front Pharmacol; 2019; 10():776. PubMed ID: 31354491
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of paclitaxel and rapamycin individual and dual drug-loaded polymeric micelles in the angiogenic cascade.
Mishra GP; Nguyen D; Alani AW
Mol Pharm; 2013 May; 10(5):2071-8. PubMed ID: 23590802
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline.
Gude RP; Binda MM; Boquete AL; Bonfil RD
J Cancer Res Clin Oncol; 2001 Oct; 127(10):625-30. PubMed ID: 11599799
[TBL] [Abstract][Full Text] [Related]
4. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.
Aozuka Y; Koizumi K; Saitoh Y; Ueda Y; Sakurai H; Saiki I
Cancer Lett; 2004 Dec; 216(1):35-42. PubMed ID: 15500947
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo.
Hong SJ; Wan JB; Zhang Y; Hu G; Lin HC; Seto SW; Kwan YW; Lin ZX; Wang YT; Lee SM
Phytother Res; 2009 May; 23(5):677-86. PubMed ID: 19107746
[TBL] [Abstract][Full Text] [Related]
7. Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial-mesenchymal transition and inducing apoptosis.
Xue YN; Yu BB; Liu YN; Guo R; Li JL; Zhang LC; Su J; Sun LK; Li Y
Prostate; 2019 May; 79(6):647-656. PubMed ID: 30714183
[TBL] [Abstract][Full Text] [Related]
8. Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.
Sootichote R; Thuwajit P; Singsuksawat E; Warnnissorn M; Yenchitsomanus PT; Ithimakin S; Chantharasamee J; Thuwajit C
BMC Cancer; 2018 Feb; 18(1):231. PubMed ID: 29486738
[TBL] [Abstract][Full Text] [Related]
9. Low-dose irradiation and short-exposure suboptimal-dose paclitaxel adversely modulate metastatic potential of squamous carcinoma cells.
Lövey J; Fazekas K; Ladányi A; Németh G; Tímár J
Strahlenther Onkol; 2003 Dec; 179(12):812-8. PubMed ID: 14652669
[TBL] [Abstract][Full Text] [Related]
10. Surface modification of MPEG-b-PCL-based nanoparticles via oxidative self-polymerization of dopamine for malignant melanoma therapy.
Xiong W; Peng L; Chen H; Li Q
Int J Nanomedicine; 2015; 10():2985-96. PubMed ID: 25945046
[TBL] [Abstract][Full Text] [Related]
11. The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models.
Zhang W; Shi Y; Chen Y; Hao J; Sha X; Fang X
Biomaterials; 2011 Sep; 32(25):5934-44. PubMed ID: 21596432
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
[TBL] [Abstract][Full Text] [Related]
13. SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation.
Wang J; Yang Z; Wen J; Ma F; Wang F; Yu K; Tang M; Wu W; Dong Y; Cheng X; Nie C; Chen L
J Pharmacol Sci; 2014; 126(3):198-207. PubMed ID: 25341684
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of the antimetastatic efficacy of Pentoxifylline on A375 human melanoma cell line.
Kamran MZ; Gude RP
Biomed Pharmacother; 2012 Dec; 66(8):617-26. PubMed ID: 23089470
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel.
Luo LM; Huang Y; Zhao BX; Zhao X; Duan Y; Du R; Yu KF; Song P; Zhao Y; Zhang X; Zhang Q
Biomaterials; 2013 Jan; 34(4):1102-14. PubMed ID: 23127332
[TBL] [Abstract][Full Text] [Related]
16. Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance.
Borghese C; Casagrande N; Corona G; Aldinucci D
Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32349462
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
18. Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model.
Han X; Dong X; Li J; Wang M; Luo L; Li Z; Lu X; He R; Xu R; Gong M
Int J Pharm; 2017 Aug; 528(1-2):33-46. PubMed ID: 28576551
[TBL] [Abstract][Full Text] [Related]
19. Stereocomplex micelle loaded with paclitaxel for enhanced therapy of breast cancer in an orthotopic mouse model.
Piao L; Li Y; Zhang H; Jiang J
J Biomater Sci Polym Ed; 2019 Feb; 30(3):233-246. PubMed ID: 30606090
[TBL] [Abstract][Full Text] [Related]
20. Gambogic acid exhibits anti-metastatic activity on malignant melanoma mainly through inhibition of PI3K/Akt and ERK signaling pathways.
Li CY; Wang Q; Wang XM; Li GX; Shen S; Wei XL
Eur J Pharmacol; 2019 Dec; 864():172719. PubMed ID: 31586634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
